considerations evaluation starting glp-1 Group Starts for RA Therapies GLP-1-based therapies for diabetes, obesity

However, based on anecdotal evidence and limited research, there are a few safety considerations to be aware of

Those with uncontrolled endocrine disorders or severe autoimmune conditions may also face higher risks

Dont put your health at risk chasing unproven solutions

We are affiliated with the Industrial Areas Foundation, the oldest and largest citizens power network in the United States

Insurers often deny coverage because it is considered an off-label treatment for most conditions, unless a patient has been diagnosed with either diabetes or obesity

doi:10.1016/S0140-6736(21)01751-7 Dutta D, Nagendra L, Harish BG, et al